To study the variation of glucose and its management in patients with insulinomas
10.3760/cma.j.issn.1007-8118.2011.01.005
- VernacularTitle:胰岛素瘤患者围手术期血糖变化规律及处理
- Author:
Hanxiang ZHAN
;
Yupei ZHAO
;
Taiping ZHANG
;
Lin CONG
;
Quan LIAO
;
Menghua DAI
- Publication Type:Journal Article
- Keywords:
Insulinoma;
Glucose;
Surgical treatment;
Multiple endocrine neoplasia type 1
- From:
Chinese Journal of Hepatobiliary Surgery
2011;17(1):13-16
- CountryChina
- Language:Chinese
-
Abstract:
Objective To retrospectively study the variation of glucose in patients with insulinomas. Methods The medical records of patients who underwent operations in the last 20 years at Peking Union Medical College Hospital were reviewed retrospectively. Patients who received repeated operations, or just exploratory laparotomy or liver biopsy were excluded. The clinical data were collected and analyzed. Results There were 245 patients, including 103 males and 142 females. The mean age was (42.2+ 14.6) years old. The mean value of preoperative fasting glucose was (1.47+0. 57) mmol/L, and the ratio of insulin to glucose was greater than 0.3 in 87.4% patients. The glucose level rose gradually after removal of the tumor(s). The blood sugar rising more than 1 time over the baseline value at one hour after resection was observed in 79.6% patients. For all the other patients, the glucose level rose to this level in the morning of the first postoperative Day 1. Rebound hyperglycemia was common after operations, and the glucose gradually returned to normal, with a mean level of 5.56 mmol/L at the time when the patients were discharged home. Conclusions Patients with insulinomas had a serum fluctuation in glucose (low→high→normal) during the perioperative period.Intraoperative glucose test combined with ultrasound and frozen section helped to localize and to remove all the lesions. Rebound hyperglycemia after surgery should be treated with insulin pump actively to minimize the incidence of complications.
